The purpose of this study is determine if you have too much fat in your body that it will
decrease the conversion of food energy into energy that your body can use.
Other: Lipid infusion and muscle biopsies
We will connect you to the doctor responsible for this trial and help you get more information.
Locations near you
Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Full eligibility criteria for NCT01724515
Ages eligible for Study
21 Years to 55 Years
Genders eligible for Study
Accepts Healthy Volunteers
Subjects must be able to communicate meaningfully with the investigator and must be legally competent to provide written informed consent.
Subjects may be of either sex with age as described in each protocol. Female subjects must be non-lactating and will be eligible only if they have a negative pregnancy test throughout the study period.
Subjects must range in age as described in each specific protocol.
Subjects must have the following laboratory values:
Hematocrit ≥ 35 vol%
Serum creatinine ≤ 1.6 mg/dl
Aspartate Aminotransferase (AST) (SGOT) < 2 times upper limit of normal
Alanine Aminotransferase (ALT) (SGPT) < 2 times upper limit of normal
Alkaline phosphatase < 2 times upper limit of normal
Triglycerides < 150 mg/dl.
Prothrombin Time (PT) 11.7 - 14.3 seconds (during Intralipid/heparin infusion, PT will be determined to insure that it is < 1.5-2.0 times the normal value.)
Partial Thromboplastin Time (PTT) 23.0-37.0 seconds.
Subjects must not be receiving any of the following medications: thiazide or furosemide diuretics, beta-blockers, or other chronic medications with known adverse effects on glucose tolerance levels unless the patient has been on a stable dose of such agents for the past three months before entry into the study. Subjects may be taking a stable dose of estrogens or other hormonal replacement therapy, if the subject has been on these agents for the prior three months. Subjects taking systemic glucocorticoids are excluded.
Subjects with a history of clinically significant heart disease (New York Heart Classification greater than grade II; more than non-specific ST-T wave changes on the EKG), peripheral vascular disease (history of claudication), or pulmonary disease
(dyspnea on exertion of one flight or less; abnormal breath sounds on auscultation) will not be studied.
Tris trial is registered with FDA with number: NCT01724515. The sponsor of the trial is Mayo Clinic and it is looking for 16 volunteers for the current phase.
Official trial title: PGC-1 and Mitochondrial Dysfunction in Diabetes
1What's a trial
4Get in touch
What's a trial
Not sure you're well informed about clinical trials? Learn more about their benefits, risks and other important details.
Enter your details like condition, age, gender and other preferences and we will show you a list of all relevant clinical trials.
Review the summary of the selected clinical trial and all the locations near you in order to see if it's of interest to you.
Get in touch
You've found an interesting trial? We'll need a bit more information about you so we can connect you to the doctor in charge.
Thank you for applying!
We'll contact you soon with more information.
Consult your doctor?
Some people want to consult their doctor before considering participation in a clinical trial. This is absolutely normal as your doctor should know your medical history and should be able to advise you. If you want you can easily share the information for this trial with your doctor by clicking on the button below.